Objective -
Studies in vitro and in animals suggest that the methyxantines like caffeine are competitive antagonists of adenosine (ADO) receptors A 1 and A 2 1 . A 1 receptors, at higher concentrations in the central nervous system (CNS), have high binding capability to ADO, which in the CNS has a neurodepressor action, through the inhibition of the release of norepinephrine, dopamine, gamma-aminobutyric acid (GABA), and glutamate. Through the inhibition of adenylate cyclase, and the subsequent decrease in intracellular cyclic adenosine monophosphate (AMPc), A 1 receptors also cause bronchoconstriction, reduce myocardial contractility, reduce A-V conduction, and cause constriction of the afferent renal arteriole. By binding to A 2 receptors, ADO causes activation of adenylate cyclase, leading to peripheral and cerebral vasodilation 1 . The effects of caffeine on arterial blood pressure (BP) are controversial 2 . Some studies suggest that its action on peripheral vascular resistance (PVR) is weaker than its effect on the CNS that leads to an increase in PVR 3 . On the other hand, studies in individuals with autonomous defects demonstrate that the peripheral effect plays an important role in the increase of PVR 4 . Caffeine causes this effect by blocking A 1 receptors (central), increasing the release of vasoconstrictive substances and by blocking A 2 receptors (peripheral), leading to vasoconstriction.
With regard to platelet aggregation (PA), studies in vitro point to caffeine as being a phosphodiesterase blocker, blocking the conversion of AMPc to 5-AMP, leading to an increase in AMPc and subsequent inhibition of PA 3 . However, controversy appears when it is demonstrated that caffeine, by blocking ADO A 2 receptors (on platelet surfaces), leads to PA 5 ( fig. 1 ). Because of the existing controversies and considering the usual habit in our country and all over the world of consumption of coffee and other caffeine-containing products, with a consumption of 15mg/kg/day in the United States and Canada 6 , we decided to investigate the effects of caffeine on BP and PA behavior, as well as to observe the clinical effects of its use. The handgrip pressor test was chosen be-cause it is a standard stimulus for the sympathetic system, and we sought to observe whether it is potentiated by caffeine.
Methods
Thirteen volunteers, aged 21 to 27, participated in the study. They were clinically healthy, with no addictions and did not use medications (table I) . The Vanderbilt Clinical Research Center protocol (modified) 7 was used ( fig. 2) , and the guidelines of the National Council of Health 8 were observed for the execution of the research. The study consisted, initially, of 7 days of abstinence from caffeine-containing products, followed by 7 days of daily intake of 750mg of caffeine, divided into three doses of 250mg (capsules), and then followed by 7 days of abstinence. BP behavior was observed with the use of the handgrip pressor test (HPT), which consisted of maintaining 30% of maximum force for 2 minutes; the BP measurement was taken with the auscultatory method with a mercury column sphygmomanometer, before the test (basal measure), immediately after it, and every 2 minutes until the 8 th minute after the stimulus, on the nondominant arm and with the participant in the supine position. Systolic and diastolic pressures were considered as the 1 st and 5 th Korotkoff phases, respectively. For the study of PA, we used platelet rich plasma (PRP) obtained from venous blood samples collected in silicon test tubes, with sodium citrate at 3.8% and coagulant, avoiding both trauma and stasis during the puncture. The number of platelets in the PRP was standardized at 300,000/mm 3 .
The aggregate agents used were adenosine diphosphate (ADP), adrenalin, and native collagen from equine tendon. 
Results
Two of the 13 volunteers in the study dropped out. One of them because of an important side effect, and the other as a consequence of acute appendicitis.
During caffeine intake, the most common symptoms were insomnia (84.6%), tremors (46.1%), nausea (38.4%), polyuria (23%), diarrhea (15,4%), and polyphagia (15.4%); these symptoms were attenuated or disappeared with chronic caffeine use. After 24 hours of caffeine cessation, all volunteers experienced headaches and sleepiness, symptoms that disappeared after the 60 th hour. Systolic BP was not significantly elevated in any phase of the study. Diastolic BP, however, was significantly elevated in the acute phase (p<0.05), a phenomenon that disappeared in the chronic phase ( fig.1 ). Comparing diastolic BP basal values before caffeine intake and 24 hours after its withdrawal (acute abstinence), we observed a significant fall from 65 to 60.4m-mHg (p<0.05) ( fig. 3 ). Comparing BP values during the HPT applied in the acute phase of caffeine use with those obtained during the acute phase of caffeine abstinence, we verified a significant decline in diastolic BP from 69.5 to 62 mm Hg (p<0.01) (fig. 4) . No significant alteration occurred in the PA during any phase of the study ( fig. 5 ).
Discussion
Studies demonstrate that caffeine is a lipophilic component rapidly absorbed by the CNS 9 . Therefore, by caffeine induced inhibitory action on A 1 receptors of ADO, abundant in CNS, a neurostimulating effect occurs through the release of dopamine, adrenaline, GABA, and glutamate in many regions of the CNS. This finding was noted clinically in the present study by the appearance of insomnia, tremors, and irritability during caffeine intake, this effect being stronger in the acute phase. After 24 hours of caffeine interruption (acute abstinence), the volunteers experienced intense headache and sleepiness, probably because of cerebral vasodilatation and the neurodepressor effect, respectively. Those clinical manifestations are explained by the increase in ADO receptors A 1 and A 2 because of chronic caffeine use. These receptors, during acute abstinence, have a high affinity for ADO and interact more actively with G protein, through the adenylate cyclase system 10 . The cli- nical manifestations corresponding to these caffeine effects disappeared within the 60 th and the 72 nd hour after the last caffeine dose.
The others clinical manifestations observed with acute caffeine use are related to its action on the phosphodiesterase receptors of smooth muscles, leading to an increase in AMPc levels and, consequently, to vasodilation of afferent renal arterioles, which explains the appearance of polyuria and decreased tonus of the lower esophageal sphincter, leading to gastroesophageal reflux, which manifests clinically as pyrosis, nausea, and anorexia. Besides that, high levels of AMPc on the smooth muscle of the gastrointestinal tract lead to an increase in motility, which manifested clinically as diarrhea and polyphagia in some of our volunteers, as reported by Benowitz 6 . With chronic caffeine use, a reduction or disappearance of symptoms was observed, a fact 
